Diabetes and Cancer: A parallel diagnosis - PowerPoint PPT Presentation

About This Presentation
Title:

Diabetes and Cancer: A parallel diagnosis

Description:

There doesn't seem to be any higher risk for other cancers, such as lung cancer. The risk of prostate cancer is actually lower among diabetics. – PowerPoint PPT presentation

Number of Views:25
Avg rating:3.0/5.0
Slides: 27
Provided by: jefflineJ
Category:

less

Transcript and Presenter's Notes

Title: Diabetes and Cancer: A parallel diagnosis


1
Diabetes and Cancer A parallel diagnosis
  • Kate McHenry BSN, RN
  • 3W Oncology Unit

2
To Be Discussed
  • Overview of diabetes, cancer, and interactions
    between the two
  • Increased risk of certain cancers with the
    comorbid condition of diabetes
  • Glucose control in the management of diabetes in
    patients with cancer
  • Cancer treatment and side effects in patient with
    diabetes

3
Diabetes and cancer are two of the top three
killers in the United States
4
DIABETES
  • 8 of the U.S. population (or 25.8 million
    people) have diabetes
  • One in three people born in the U.S. in 2000 are
    projected to develop diabetes at some point in
    their lifetime

5
CANCER
  • One in four deaths in the U.S. is caused by
    cancer
  • Most common and fatal cancers in men include
    prostate, lung, bronchus, colorectal
  • Most common and fatal cancers in women include
    lung, breast, colorectal
  • The GOOD NEWS the number of people becoming
    long-term survivors is increasing
  • The BAD NEWS a greater number of patients will
    have to face the challenge of living with both
    cancer and diabetes

6
Is there really a link between diabetes and
cancer?
7
Risk factors in cancer and diabetes
  • Age
  • Race/ethnicity
  • Sex (men have a higher risk for both cancer and
    diabetes)
  • Obesity
  • Physical activity
  • Diet
  • Alcohol
  • Smoking

8
Diabetes causes cancer?
  • Many cells in the body have surface receptors for
    insulin and insulin-like growth factors that have
    been shown in lab tests to stimulate the growth
    and metastasis of cancer cells.
  • About half of Type 2 diabetes and all Type 1's
    take insulin daily, and their blood-insulin
    levels spike higher than normal.
  • Diabetic patients also have episodes of higher
    than normal blood sugar, which may promote cell
    cancer growth.

9
Cancer Survival
10
Hyperglycemia causes increased risk for
infection, and higher rates of cancer recurrence
and mortality
11
  • Diabetics are twice as likely to get cancer of
    the liver, pancreas and uterine lining. Their
    risk of colon, breast, and bladder cancer is 20
    to 50 percent higher than non-diabetics'.
  • There doesn't seem to be any higher risk for
    other cancers, such as lung cancer.
  • The risk of prostate cancer is actually lower
    among diabetics.

12
Colorectal Cancer
  • Elevated postprandial insulin have shown to
    increase colorectal cancer risk (Meyerhardt et
    al, 2003)
  • Several studies show that patients with diabetes
    and stage II and III colon cancer had
    significantly higher rates of overall mortality
  • Patients with diabetes often have delayed stool
    transit and gastrointestinal abnormalities, which
    are associated with colorectal cancer (Will et
    al, 1998)

13
Breast Cancer
  • Women with the highest fasting insulin levels had
    two-fold increased risk of distant cancer
    recurrence and three-fold increased risk of death
    compared to those with lower insulin levels
    (Coughlin et al, 2004, Goodwin et al, 2002)

14
  • In a study (Weiser, et al 2004), the complete
    remission duration, survival, and
    treatment-related complications were compared in
    patients with and without hyperglycemia
  • Patients with hyperglycemia had shorter complete
    remission (24 versus 52 months)
  • Shorter median survival (29 versus 88 months)
  • More likely to develop a complicated infection
    (39 versus 25)

15
So is there a link between cancer and diabetes?
  • Yes and No
  • Studies remain inconclusive on the connection
  • A link appears to be more prevalent between
    diabetes and certain cancers, i.e. breast and
    colon
  • There appears to be enough of a connection to
    warrant consideration when treating a patient
    with this dual diagnosis

16
Caring for patients with both diabetes and cancer
17
Complications from elevated blood glucose
  • Macrovascular injury to the large blood vessels
    of the heart and brain, most commonly occur in
    coronary arteries and large vessels of the legs
    CAD, atherosclerosis
  • Microvascular injury to capillaries throughout
    the body, to organs such as the eyes and kidneys,
    retinopathy, nephropathy
  • Neurologic neuropathy

18
Patients with diabetes and chemotherapy treatments
  • Pre-existing renal, cardiac, or neuropathic
    complications
  • Chemotherapy agents exacerbate these
    complications
  • Cisplatin causes renal insufficiency
  • Anthracyclines cause cardiotoxicity
  • Cisplatin, pacitaxel, vincristine are neurotoxic
  • Many of these side effects are permanent and
    irreversible, and diabetics have underlying
    predisposition

19
Hyperglycemia and Cancer Treatment
20
Chemotherapy
  • Chemotherapy is the leading treatment option
    available for cancer
  • Chemotherapy can alter glucose metabolism
    Androgen suppression therapy, used in patients
    with prostate cancer, affects insulin resistance
    and increase diabetes or hyperglycemia

21
  • Supportive medications, high-dose steroids,
    elevated blood glucose
  • Steroids induce a hypermetabolic state by
    decreasing glucose uptake, increased hepatic
    glucose production, and inhibiting insulin
    release
  • So, glucocorticoids increase postprandial
    hyperglycemia, and fasting hyperglycemia
  • Induction of chemotherapy treatment is often
    preceded with steroid therapy, this can cause a
    patient already predisposed to diabetes to
    progress to type 2

22
Managing hyperglycemia in patients on
glucocorticoids
  • Patients with pre-existing diabetes may be kept
    on their oral hypoglycemic agents and monitored
    carefully. However, these agents are usually
    inadequate for managing hyperglycemia
  • These patients may require two to three times
    their usual dose(s) of insulin.
  • Insulin is the preferred drug for managing
    steroid-induced or exacerbated hyperglycemia in
    patients with known diabetes. Many patients will
    require basal and prandial bolus insulins to
    attain adequate glycemic control

23
  • Hyperglycemia has been associated with increased
    hospital mortality in critically ill patients
  • New hyperglycemia in any serious ill patient
    results in poorer clinical outcomes

24
Nausea and Vomiting
  • Nausea and vomiting are common adverse reactions
    to chemotherapy
  • Patients with diabetes should be assessed
    frequently for nausea and vomiting, hydration
    status, ability to eat and drink, and level of
    glycemic control

25
Conclusions
  • Both diabetes and cancer are complex diseases
    that require careful management
  • When a patient is diagnosed with both diseases,
    there may be a connection, and patient care
    becomes even more complicated
  • A well developed understanding of both diseases,
    and the possible connections between the two, can
    lead to better patient care and better
    potentially patient outcomes

26
  • Center for Disease Control and Prevention CDC,
    2011
  • December 2011, Volume 15, Number 6, Clinical
    Journal of Oncology Nursing
  • Clinical Journal of Oncology Nursing, Volume 13,
    Number 2, Diabetes Management and Self-Care
    Education
  • Diabetes and Cancer A Consensus Report 2010
    American Diabetes Association and the American
    Cancer Society
  • Diabetes Spectrum, Volume 19, Number 3, 2006
    Clinical Challenges in Caring for Patients with
    Diabetes and Cancer
Write a Comment
User Comments (0)
About PowerShow.com